Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron Switching Study in OAB
NCT02468375Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Jun 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in overactive bladder (OAB), sponsored by Samsung Medical Center. Started Jun 2015; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02468375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468375.